The global Severe Asthma Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Severe Asthma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Severe Asthma Treatment.

Report Scope

The Severe Asthma Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Severe Asthma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Severe Asthma Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Severe Asthma Treatment Market Report

Report Metric	Details
Report Name	Severe Asthma Treatment Market
CAGR	5%
Segment by Type	Oral lnhaled lntravenous Subcutaneous
Segment by Application	Children Adults Teenagers
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Regeneron Pharmaceutical, 4D Pharma plc, AB Pharma, Morphosys, Roche, Avalo Therapeutics, Suzhou Connect Biopharmaceuticals, Pieris Pharma, Biosion
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Severe Asthma Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Severe Asthma Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Severe Asthma Treatment Market report?

Ans: The main players in the Severe Asthma Treatment Market are Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Regeneron Pharmaceutical, 4D Pharma plc, AB Pharma, Morphosys, Roche, Avalo Therapeutics, Suzhou Connect Biopharmaceuticals, Pieris Pharma, Biosion

What are the Application segmentation covered in the Severe Asthma Treatment Market report?

Ans: The Applications covered in the Severe Asthma Treatment Market report are Children, Adults, Teenagers

What are the Type segmentation covered in the Severe Asthma Treatment Market report?

Ans: The Types covered in the Severe Asthma Treatment Market report are Oral, lnhaled, lntravenous, Subcutaneous

1 Severe Asthma Treatment Market Overview

1.1 Product Overview and Scope of Severe Asthma Treatment

1.2 Severe Asthma Treatment Segment by Type

1.2.1 Global Severe Asthma Treatment Market Value Comparison by Type (2024-2030)

1.2.2 Oral

1.2.3 lnhaled

1.2.4 lntravenous

1.2.5 Subcutaneous

1.3 Severe Asthma Treatment Segment by Application

1.3.1 Global Severe Asthma Treatment Market Value by Application: (2024-2030)

1.3.2 Children

1.3.3 Adults

1.3.4 Teenagers

1.4 Global Severe Asthma Treatment Market Size Estimates and Forecasts

1.4.1 Global Severe Asthma Treatment Revenue 2019-2030

1.4.2 Global Severe Asthma Treatment Sales 2019-2030

1.4.3 Global Severe Asthma Treatment Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Severe Asthma Treatment Market Competition by Manufacturers

2.1 Global Severe Asthma Treatment Sales Market Share by Manufacturers (2019-2024)

2.2 Global Severe Asthma Treatment Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Severe Asthma Treatment Average Price by Manufacturers (2019-2024)

2.4 Global Severe Asthma Treatment Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Severe Asthma Treatment, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Severe Asthma Treatment, Product Type & Application

2.7 Severe Asthma Treatment Market Competitive Situation and Trends

2.7.1 Severe Asthma Treatment Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Severe Asthma Treatment Players Market Share by Revenue

2.7.3 Global Severe Asthma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Severe Asthma Treatment Retrospective Market Scenario by Region

3.1 Global Severe Asthma Treatment Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Severe Asthma Treatment Global Severe Asthma Treatment Sales by Region: 2019-2030

3.2.1 Global Severe Asthma Treatment Sales by Region: 2019-2024

3.2.2 Global Severe Asthma Treatment Sales by Region: 2025-2030

3.3 Global Severe Asthma Treatment Global Severe Asthma Treatment Revenue by Region: 2019-2030

3.3.1 Global Severe Asthma Treatment Revenue by Region: 2019-2024

3.3.2 Global Severe Asthma Treatment Revenue by Region: 2025-2030

3.4 North America Severe Asthma Treatment Market Facts & Figures by Country

3.4.1 North America Severe Asthma Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Severe Asthma Treatment Sales by Country (2019-2030)

3.4.3 North America Severe Asthma Treatment Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Severe Asthma Treatment Market Facts & Figures by Country

3.5.1 Europe Severe Asthma Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Severe Asthma Treatment Sales by Country (2019-2030)

3.5.3 Europe Severe Asthma Treatment Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Severe Asthma Treatment Market Facts & Figures by Country

3.6.1 Asia Pacific Severe Asthma Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Severe Asthma Treatment Sales by Country (2019-2030)

3.6.3 Asia Pacific Severe Asthma Treatment Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Severe Asthma Treatment Market Facts & Figures by Country

3.7.1 Latin America Severe Asthma Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Severe Asthma Treatment Sales by Country (2019-2030)

3.7.3 Latin America Severe Asthma Treatment Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Severe Asthma Treatment Market Facts & Figures by Country

3.8.1 Middle East and Africa Severe Asthma Treatment Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Severe Asthma Treatment Sales by Country (2019-2030)

3.8.3 Middle East and Africa Severe Asthma Treatment Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Severe Asthma Treatment Sales by Type (2019-2030)

4.1.1 Global Severe Asthma Treatment Sales by Type (2019-2024)

4.1.2 Global Severe Asthma Treatment Sales by Type (2025-2030)

4.1.3 Global Severe Asthma Treatment Sales Market Share by Type (2019-2030)

4.2 Global Severe Asthma Treatment Revenue by Type (2019-2030)

4.2.1 Global Severe Asthma Treatment Revenue by Type (2019-2024)

4.2.2 Global Severe Asthma Treatment Revenue by Type (2025-2030)

4.2.3 Global Severe Asthma Treatment Revenue Market Share by Type (2019-2030)

4.3 Global Severe Asthma Treatment Price by Type (2019-2030)

5 Segment by Application

5.1 Global Severe Asthma Treatment Sales by Application (2019-2030)

5.1.1 Global Severe Asthma Treatment Sales by Application (2019-2024)

5.1.2 Global Severe Asthma Treatment Sales by Application (2025-2030)

5.1.3 Global Severe Asthma Treatment Sales Market Share by Application (2019-2030)

5.2 Global Severe Asthma Treatment Revenue by Application (2019-2030)

5.2.1 Global Severe Asthma Treatment Revenue by Application (2019-2024)

5.2.2 Global Severe Asthma Treatment Revenue by Application (2025-2030)

5.2.3 Global Severe Asthma Treatment Revenue Market Share by Application (2019-2030)

5.3 Global Severe Asthma Treatment Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Teva Pharmaceutical

6.1.1 Teva Pharmaceutical Corporation Information

6.1.2 Teva Pharmaceutical Description and Business Overview

6.1.3 Teva Pharmaceutical Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Teva Pharmaceutical Severe Asthma Treatment Product Portfolio

6.1.5 Teva Pharmaceutical Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Corporation Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AstraZeneca Severe Asthma Treatment Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 GlaxoSmithKline

6.3.1 GlaxoSmithKline Corporation Information

6.3.2 GlaxoSmithKline Description and Business Overview

6.3.3 GlaxoSmithKline Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.3.4 GlaxoSmithKline Severe Asthma Treatment Product Portfolio

6.3.5 GlaxoSmithKline Recent Developments/Updates

6.4 Novartis

6.4.1 Novartis Corporation Information

6.4.2 Novartis Description and Business Overview

6.4.3 Novartis Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novartis Severe Asthma Treatment Product Portfolio

6.4.5 Novartis Recent Developments/Updates

6.5 Sanofi

6.5.1 Sanofi Corporation Information

6.5.2 Sanofi Description and Business Overview

6.5.3 Sanofi Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Sanofi Severe Asthma Treatment Product Portfolio

6.5.5 Sanofi Recent Developments/Updates

6.6 Regeneron Pharmaceutical

6.6.1 Regeneron Pharmaceutical Corporation Information

6.6.2 Regeneron Pharmaceutical Description and Business Overview

6.6.3 Regeneron Pharmaceutical Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Regeneron Pharmaceutical Severe Asthma Treatment Product Portfolio

6.6.5 Regeneron Pharmaceutical Recent Developments/Updates

6.7 4D Pharma plc

6.6.1 4D Pharma plc Corporation Information

6.6.2 4D Pharma plc Description and Business Overview

6.6.3 4D Pharma plc Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.4.4 4D Pharma plc Severe Asthma Treatment Product Portfolio

6.7.5 4D Pharma plc Recent Developments/Updates

6.8 AB Pharma

6.8.1 AB Pharma Corporation Information

6.8.2 AB Pharma Description and Business Overview

6.8.3 AB Pharma Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.8.4 AB Pharma Severe Asthma Treatment Product Portfolio

6.8.5 AB Pharma Recent Developments/Updates

6.9 Morphosys

6.9.1 Morphosys Corporation Information

6.9.2 Morphosys Description and Business Overview

6.9.3 Morphosys Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Morphosys Severe Asthma Treatment Product Portfolio

6.9.5 Morphosys Recent Developments/Updates

6.10 Roche

6.10.1 Roche Corporation Information

6.10.2 Roche Description and Business Overview

6.10.3 Roche Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Roche Severe Asthma Treatment Product Portfolio

6.10.5 Roche Recent Developments/Updates

6.11 Avalo Therapeutics

6.11.1 Avalo Therapeutics Corporation Information

6.11.2 Avalo Therapeutics Severe Asthma Treatment Description and Business Overview

6.11.3 Avalo Therapeutics Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Avalo Therapeutics Severe Asthma Treatment Product Portfolio

6.11.5 Avalo Therapeutics Recent Developments/Updates

6.12 Suzhou Connect Biopharmaceuticals

6.12.1 Suzhou Connect Biopharmaceuticals Corporation Information

6.12.2 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Description and Business Overview

6.12.3 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Portfolio

6.12.5 Suzhou Connect Biopharmaceuticals Recent Developments/Updates

6.13 Pieris Pharma

6.13.1 Pieris Pharma Corporation Information

6.13.2 Pieris Pharma Severe Asthma Treatment Description and Business Overview

6.13.3 Pieris Pharma Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Pieris Pharma Severe Asthma Treatment Product Portfolio

6.13.5 Pieris Pharma Recent Developments/Updates

6.14 Biosion

6.14.1 Biosion Corporation Information

6.14.2 Biosion Severe Asthma Treatment Description and Business Overview

6.14.3 Biosion Severe Asthma Treatment Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Biosion Severe Asthma Treatment Product Portfolio

6.14.5 Biosion Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Severe Asthma Treatment Industry Chain Analysis

7.2 Severe Asthma Treatment Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Severe Asthma Treatment Production Mode & Process

7.4 Severe Asthma Treatment Sales and Marketing

7.4.1 Severe Asthma Treatment Sales Channels

7.4.2 Severe Asthma Treatment Distributors

7.5 Severe Asthma Treatment Customers

8 Severe Asthma Treatment Market Dynamics

8.1 Severe Asthma Treatment Industry Trends

8.2 Severe Asthma Treatment Market Drivers

8.3 Severe Asthma Treatment Market Challenges

8.4 Severe Asthma Treatment Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Teva Pharmaceutical

Astrazeneca plc

Novartis

Regeneron Pharmaceutical

Suzhou Connect Biopharmaceuticals

Pieris Pharma

Biosion

List of Tables

Table 1. Global Severe Asthma Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Severe Asthma Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Severe Asthma Treatment Market Competitive Situation by Manufacturers in 2023

Table 4. Global Severe Asthma Treatment Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Severe Asthma Treatment Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Severe Asthma Treatment Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Severe Asthma Treatment Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Severe Asthma Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Severe Asthma Treatment, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Severe Asthma Treatment, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Severe Asthma Treatment, Product Type & Application

Table 12. Global Key Manufacturers of Severe Asthma Treatment, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Severe Asthma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Severe Asthma Treatment as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Severe Asthma Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Severe Asthma Treatment Sales by Region (2019-2024) & (K Units)

Table 18. Global Severe Asthma Treatment Sales Market Share by Region (2019-2024)

Table 19. Global Severe Asthma Treatment Sales by Region (2025-2030) & (K Units)

Table 20. Global Severe Asthma Treatment Sales Market Share by Region (2025-2030)

Table 21. Global Severe Asthma Treatment Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Severe Asthma Treatment Revenue Market Share by Region (2019-2024)

Table 23. Global Severe Asthma Treatment Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Severe Asthma Treatment Revenue Market Share by Region (2025-2030)

Table 25. North America Severe Asthma Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Severe Asthma Treatment Sales by Country (2019-2024) & (K Units)

Table 27. North America Severe Asthma Treatment Sales by Country (2025-2030) & (K Units)

Table 28. North America Severe Asthma Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Severe Asthma Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Severe Asthma Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Severe Asthma Treatment Sales by Country (2019-2024) & (K Units)

Table 32. Europe Severe Asthma Treatment Sales by Country (2025-2030) & (K Units)

Table 33. Europe Severe Asthma Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Severe Asthma Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Severe Asthma Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Severe Asthma Treatment Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Severe Asthma Treatment Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Severe Asthma Treatment Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Severe Asthma Treatment Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Severe Asthma Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Severe Asthma Treatment Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Severe Asthma Treatment Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Severe Asthma Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Severe Asthma Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Severe Asthma Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Severe Asthma Treatment Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Severe Asthma Treatment Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Severe Asthma Treatment Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Severe Asthma Treatment Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Severe Asthma Treatment Sales (K Units) by Type (2019-2024)

Table 51. Global Severe Asthma Treatment Sales (K Units) by Type (2025-2030)

Table 52. Global Severe Asthma Treatment Sales Market Share by Type (2019-2024)

Table 53. Global Severe Asthma Treatment Sales Market Share by Type (2025-2030)

Table 54. Global Severe Asthma Treatment Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Severe Asthma Treatment Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Severe Asthma Treatment Revenue Market Share by Type (2019-2024)

Table 57. Global Severe Asthma Treatment Revenue Market Share by Type (2025-2030)

Table 58. Global Severe Asthma Treatment Price (US$/Unit) by Type (2019-2024)

Table 59. Global Severe Asthma Treatment Price (US$/Unit) by Type (2025-2030)

Table 60. Global Severe Asthma Treatment Sales (K Units) by Application (2019-2024)

Table 61. Global Severe Asthma Treatment Sales (K Units) by Application (2025-2030)

Table 62. Global Severe Asthma Treatment Sales Market Share by Application (2019-2024)

Table 63. Global Severe Asthma Treatment Sales Market Share by Application (2025-2030)

Table 64. Global Severe Asthma Treatment Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Severe Asthma Treatment Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Severe Asthma Treatment Revenue Market Share by Application (2019-2024)

Table 67. Global Severe Asthma Treatment Revenue Market Share by Application (2025-2030)

Table 68. Global Severe Asthma Treatment Price (US$/Unit) by Application (2019-2024)

Table 69. Global Severe Asthma Treatment Price (US$/Unit) by Application (2025-2030)

Table 70. Teva Pharmaceutical Corporation Information

Table 71. Teva Pharmaceutical Description and Business Overview

Table 72. Teva Pharmaceutical Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Teva Pharmaceutical Severe Asthma Treatment Product

Table 74. Teva Pharmaceutical Recent Developments/Updates

Table 75. AstraZeneca Corporation Information

Table 76. AstraZeneca Description and Business Overview

Table 77. AstraZeneca Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. AstraZeneca Severe Asthma Treatment Product

Table 79. AstraZeneca Recent Developments/Updates

Table 80. GlaxoSmithKline Corporation Information

Table 81. GlaxoSmithKline Description and Business Overview

Table 82. GlaxoSmithKline Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. GlaxoSmithKline Severe Asthma Treatment Product

Table 84. GlaxoSmithKline Recent Developments/Updates

Table 85. Novartis Corporation Information

Table 86. Novartis Description and Business Overview

Table 87. Novartis Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Novartis Severe Asthma Treatment Product

Table 89. Novartis Recent Developments/Updates

Table 90. Sanofi Corporation Information

Table 91. Sanofi Description and Business Overview

Table 92. Sanofi Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Sanofi Severe Asthma Treatment Product

Table 94. Sanofi Recent Developments/Updates

Table 95. Regeneron Pharmaceutical Corporation Information

Table 96. Regeneron Pharmaceutical Description and Business Overview

Table 97. Regeneron Pharmaceutical Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Regeneron Pharmaceutical Severe Asthma Treatment Product

Table 99. Regeneron Pharmaceutical Recent Developments/Updates

Table 100. 4D Pharma plc Corporation Information

Table 101. 4D Pharma plc Description and Business Overview

Table 102. 4D Pharma plc Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. 4D Pharma plc Severe Asthma Treatment Product

Table 104. 4D Pharma plc Recent Developments/Updates

Table 105. AB Pharma Corporation Information

Table 106. AB Pharma Description and Business Overview

Table 107. AB Pharma Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. AB Pharma Severe Asthma Treatment Product

Table 109. AB Pharma Recent Developments/Updates

Table 110. Morphosys Corporation Information

Table 111. Morphosys Description and Business Overview

Table 112. Morphosys Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Morphosys Severe Asthma Treatment Product

Table 114. Morphosys Recent Developments/Updates

Table 115. Roche Corporation Information

Table 116. Roche Description and Business Overview

Table 117. Roche Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Roche Severe Asthma Treatment Product

Table 119. Roche Recent Developments/Updates

Table 120. Avalo Therapeutics Corporation Information

Table 121. Avalo Therapeutics Description and Business Overview

Table 122. Avalo Therapeutics Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Avalo Therapeutics Severe Asthma Treatment Product

Table 124. Avalo Therapeutics Recent Developments/Updates

Table 125. Suzhou Connect Biopharmaceuticals Corporation Information

Table 126. Suzhou Connect Biopharmaceuticals Description and Business Overview

Table 127. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product

Table 129. Suzhou Connect Biopharmaceuticals Recent Developments/Updates

Table 130. Pieris Pharma Corporation Information

Table 131. Pieris Pharma Description and Business Overview

Table 132. Pieris Pharma Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Pieris Pharma Severe Asthma Treatment Product

Table 134. Pieris Pharma Recent Developments/Updates

Table 135. Biosion Corporation Information

Table 136. Biosion Description and Business Overview

Table 137. Biosion Severe Asthma Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Biosion Severe Asthma Treatment Product

Table 139. Biosion Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Severe Asthma Treatment Distributors List

Table 143. Severe Asthma Treatment Customers List

Table 144. Severe Asthma Treatment Market Trends

Table 145. Severe Asthma Treatment Market Drivers

Table 146. Severe Asthma Treatment Market Challenges

Table 147. Severe Asthma Treatment Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Severe Asthma Treatment

Figure 2. Global Severe Asthma Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Severe Asthma Treatment Market Share by Type in 2023 & 2030

Figure 4. Oral Product Picture

Figure 5. lnhaled Product Picture

Figure 6. lntravenous Product Picture

Figure 7. Subcutaneous Product Picture

Figure 8. Global Severe Asthma Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Severe Asthma Treatment Market Share by Application in 2023 & 2030

Figure 10. Children

Figure 11. Adults

Figure 12. Teenagers

Figure 13. Global Severe Asthma Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Severe Asthma Treatment Market Size (2019-2030) & (US$ Million)

Figure 15. Global Severe Asthma Treatment Sales (2019-2030) & (K Units)

Figure 16. Global Severe Asthma Treatment Average Price (US$/Unit) & (2019-2030)

Figure 17. Severe Asthma Treatment Report Years Considered

Figure 18. Severe Asthma Treatment Sales Share by Manufacturers in 2023

Figure 19. Global Severe Asthma Treatment Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Severe Asthma Treatment Players: Market Share by Revenue in 2023

Figure 21. Severe Asthma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Severe Asthma Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Severe Asthma Treatment Sales Market Share by Country (2019-2030)

Figure 24. North America Severe Asthma Treatment Revenue Market Share by Country (2019-2030)

Figure 25. United States Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Severe Asthma Treatment Sales Market Share by Country (2019-2030)

Figure 28. Europe Severe Asthma Treatment Revenue Market Share by Country (2019-2030)

Figure 29. Germany Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Severe Asthma Treatment Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Severe Asthma Treatment Revenue Market Share by Region (2019-2030)

Figure 36. China Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Severe Asthma Treatment Sales Market Share by Country (2019-2030)

Figure 44. Latin America Severe Asthma Treatment Revenue Market Share by Country (2019-2030)

Figure 45. Mexico Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Severe Asthma Treatment Sales Market Share by Country (2019-2030)

Figure 49. Middle East & Africa Severe Asthma Treatment Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE Severe Asthma Treatment Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Severe Asthma Treatment by Type (2019-2030)

Figure 54. Global Revenue Market Share of Severe Asthma Treatment by Type (2019-2030)

Figure 55. Global Severe Asthma Treatment Price (US$/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of Severe Asthma Treatment by Application (2019-2030)

Figure 57. Global Revenue Market Share of Severe Asthma Treatment by Application (2019-2030)

Figure 58. Global Severe Asthma Treatment Price (US$/Unit) by Application (2019-2030)

Figure 59. Severe Asthma Treatment Value Chain

Figure 60. Severe Asthma Treatment Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Distributors Profiles

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions